Marinomed Biotech AG (VIE:MARI)
Austria · Delayed Price · Currency is EUR 5.00
+0.08 (1.63%)
Jul 21, 2026, 9:16 AM CET
Marinomed Biotech AG Revenue
In the year 2025, Marinomed Biotech AG had annual revenue of 7.69M EUR with 62.02% growth. Marinomed Biotech AG had revenue of 256.50K in the quarter ending December 31, 2025, a decrease of -77.97%.
Revenue
7.69M
Revenue Growth
+62.02%
P/S Ratio
1.24
Revenue / Employee
248.75K
Employees
32
Market Cap
9.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.69M | 2.94M | 62.02% |
| Dec 31, 2024 | 4.75M | -4.44M | -48.31% |
| Dec 31, 2023 | 9.18M | -2.09M | -18.56% |
| Dec 31, 2022 | 11.28M | -351.90K | -3.03% |
| Dec 31, 2021 | 11.63M | 3.50M | 43.12% |
| Dec 31, 2020 | 8.12M | 1.98M | 32.22% |
| Dec 31, 2019 | 6.14M | 1.48M | 31.68% |
| Dec 31, 2018 | 4.67M | -144.67K | -3.01% |
| Dec 31, 2017 | 4.81M | 2.20M | 84.45% |
| Dec 31, 2016 | 2.61M | 392.67K | 17.72% |
| Dec 31, 2015 | 2.22M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMarinomed Biotech AG News
- 3 months ago - Marinomed Biotech AG Transcript: Austrian Select Conference - Transcripts
- 3 months ago - Marinomed Biotech AG Slides: Austrian Select Conference - Filings
- 3 months ago - Marinomed Biotech AG Annual report: H2 2025 - Filings
- 5 months ago - Marinomed Biotech AG Transcript: GBC International Investment Forum - Transcripts
- 10 months ago - Marinomed Biotech AG Quarterly report: H1 2025 - Filings